Literature DB >> 4970406

Inhibition of carbonic anhydrase activity of whole erythrocytes.

P J Wistrand, P Bååthe.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4970406     DOI： 10.1111/j.1600-0773.1968.tb00434.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  5 in total

1.  Simulation of the pharmacokinetic profile of methazolamide in blood: effect of erythrocyte carbonic anhydrase binding on drug disposition.

Authors:  Malaz A AbuTarif; David R Taft
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Uptake and stereoselective binding of the enantiomers of MK-927, a potent carbonic anhydrase inhibitor, by human erythrocytes in vitro.

Authors:  J H Lin; T H Lin; H Cheng
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

3.  Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in experimental polycythemic and anemic rats.

Authors:  J H Lin; I W Chen; F A deLuna
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

4.  In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics.

Authors:  G R Iyer; R A Bellantone; D R Taft
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

5.  Carbonic anhydrase function and the epithelial organization of H+ secretion in turtle urinary bladder.

Authors:  J H Schwartz; S Rosen; P R Steinmetz
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.